Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Najjar

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Blood|July 9, 1999
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imagingG Jerusalem, Y Beguin, M F Fassotte, et al.
Journal of Vascular Surgery|March 1, 1997
Transforming growth factor beta 1 inhibits the proliferative effect of insulin on human infragenicular vascular smooth muscle cellsE A Forsyth, H M Aly, S F Najjar, et al.
Haematologica|June 28, 2000
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphomaG Jerusalem, Y Beguin, M F Fassotte, et al.
Human & Experimental Toxicology|August 2, 2015
Zearalenone-induced changes in biochemical parameters, oxidative stress and apoptosis in cardiac tissue: Protective role of crocinI Ben Salem, M Boussabbeh, F Neffati, et al.
Haematologica|March 20, 2001
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's diseaseG Jerusalem, Y Beguin, M F Fassotte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)G Jerusalem, Y Beguin, F Najjar, et al.
Nuclear Medicine Communications|February 9, 1999
Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphomaG Jerusalem, V Warland, F Najjar, et al.
Annals of Nutrition & Metabolism|April 30, 2005
Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in ratR Sakly, M Bardaoui, F Neffati, et al.
Annals of Vascular Surgery|March 21, 2007
Technical limitations of carotid filter embolic protection devicesMark K Eskandari, Samer F Najjar, Jon S Matsumura, et al.
Surgery|March 1, 1988
Wandering intravascular missiles: report of five cases from the Lebanon warF Abdo, M Massad, M Slim, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Blood|July 9, 1999
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imagingG Jerusalem, Y Beguin, M F Fassotte, et al.
Journal of Vascular Surgery|March 1, 1997
Transforming growth factor beta 1 inhibits the proliferative effect of insulin on human infragenicular vascular smooth muscle cellsE A Forsyth, H M Aly, S F Najjar, et al.
Haematologica|June 28, 2000
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphomaG Jerusalem, Y Beguin, M F Fassotte, et al.
Human & Experimental Toxicology|August 2, 2015
Zearalenone-induced changes in biochemical parameters, oxidative stress and apoptosis in cardiac tissue: Protective role of crocinI Ben Salem, M Boussabbeh, F Neffati, et al.
Haematologica|March 20, 2001
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's diseaseG Jerusalem, Y Beguin, M F Fassotte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)G Jerusalem, Y Beguin, F Najjar, et al.
Nuclear Medicine Communications|February 9, 1999
Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphomaG Jerusalem, V Warland, F Najjar, et al.
Annals of Nutrition & Metabolism|April 30, 2005
Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in ratR Sakly, M Bardaoui, F Neffati, et al.
Annals of Vascular Surgery|March 21, 2007
Technical limitations of carotid filter embolic protection devicesMark K Eskandari, Samer F Najjar, Jon S Matsumura, et al.
Surgery|March 1, 1988
Wandering intravascular missiles: report of five cases from the Lebanon warF Abdo, M Massad, M Slim, et al.
Pageof 10